Dapagliflozin vs Osimertinib

Dapagliflozin vs Osimertinib: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Osimertinib.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Osimertinib — C28H33N7O2.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Osimertinib — 499.6050 g/mol.

Type: Dapagliflozin — Small molecule; Osimertinib — Small molecule.